Cargando…

The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection

Candida auris is an emerging, multi-drug resistant, health care-associated fungal pathogen. Its predominant prevalence in hospitals and nursing homes indicates its ability to adhere to and colonize the skin, or persist in an environment outside the host—a trait unique from other Candida species. Bes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Shakti, Uppuluri, Priya, Mamouei, Zeinab, Alqarihi, Abdullah, Elhassan, Hana, French, Samuel, Lockhart, Shawn R., Chiller, Tom, Edwards, John E., Ibrahim, Ashraf S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695204/ https://www.ncbi.nlm.nih.gov/pubmed/31381597 http://dx.doi.org/10.1371/journal.ppat.1007460

Ejemplares similares

NDV-3A vaccination prevents C. albicans colonization of jugular vein catheters in mice
por: Alqarihi, Abdullah, et al.
Publicado: (2019)

An evolutionarily diverged mitochondrial protein controls biofilm growth and virulence in Candida albicans
por: Mamouei, Zeinab, et al.
Publicado: (2021)

Metabolic Profiling of Candida auris, a Newly-Emerging Multi-Drug Resistant Candida Species, by GC-MS
por: Semreen, Mohammad H., et al.
Publicado: (2019)

Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens
por: Mamouei, Zeinab, et al.
Publicado: (2018)

Human Anti-Als3p Antibodies Are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal Candidiasis
por: Uppuluri, Priya, et al.
Publicado: (2018)

Candida auris: a global pathogen that has taken root in Colombia
por: Escandón, Patricia, et al.
Publicado: (2023)

Candida auris Biofilm Colonization on Skin Niche Conditions
por: Uppuluri, Priya
Publicado: (2020)

Niclosamide-loaded nanoparticles disrupt Candida biofilms and protect mice from mucosal candidiasis
por: Sutar, Yogesh, et al.
Publicado: (2022)

On the Origins of a Species: What Might Explain the Rise of Candida auris?
por: Jackson, Brendan R., et al.
Publicado: (2019)

Candida auris: A Review of Recommendations for Detection and Control in Healthcare Settings
por: Caceres, Diego H., et al.
Publicado: (2019)

Rapid and Accurate Molecular Identification of the Emerging Multidrug-Resistant Pathogen Candida auris
por: Kordalewska, Milena, et al.
Publicado: (2017)

Notes from the Field: Surveillance for Candida auris — Colombia, September 2016–May 2017
por: Escandón, Patricia, et al.
Publicado: (2018)

969. GRP78 and Integrin β1/α3 Play Disparate Roles in Epithelium Invasion During Mucormycosis
por: Alqarihi, Abdullah, et al.
Publicado: (2018)

Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis
por: Alkhazraji, Sondus, et al.
Publicado: (2020)

Potential Fifth Clade of Candida auris, Iran, 2018
por: Chow, Nancy A., et al.
Publicado: (2019)

Antibodies targeting Candida albicans Als3 and Hyr1 antigens protect neonatal mice from candidiasis
por: Singh, Shakti, et al.
Publicado: (2022)

Pharmacodynamic Optimization for the Treatment of Invasive Candida auris Infection
por: Lepak, Alexander J, et al.
Publicado: (2017)

Public Health Response to US Cases of Candida auris, a Globally Emerging, Multidrug-Resistant Yeast, 2013–2017
por: Tsay, Sharon, et al.
Publicado: (2017)

First Nine Cases of Candida auris Infection Reported in Central America: Importance of Acurate Diagnosis and Susceptibility Testing
por: Rodriguez, Ana Belen Arauz, et al.
Publicado: (2017)

678. Galactomannan Is a Biomarker of APX001 (Fosmanogepix) Efficacy in Treating Experimental Invasive Pulmonary Aspergillosis
por: Gebremariam, Teklegiorgis, et al.
Publicado: (2019)

726. APX001 (Fosmanogepix) Is Effective in an Immunosuppressed Mouse Model of Rhizopus oryzae Infection
por: Gebremariam, Teklegiorgis, et al.
Publicado: (2019)

Laboratory‐based surveillance of Candida auris in Colombia, 2016–2020
por: Escandón, Patricia, et al.
Publicado: (2021)

Invasive Infections with Multidrug-Resistant Yeast Candida auris, Colombia
por: Morales-López, Soraya E., et al.
Publicado: (2017)

Candida auris: From Multidrug Resistance to Pan-Resistant Strains
por: Ademe, Muluneh, et al.
Publicado: (2020)

Hospital-Associated Multicenter Outbreak of Emerging Fungus Candida auris, Colombia, 2016
por: Armstrong, Paige A., et al.
Publicado: (2019)

In Vitro Interactions of Echinocandins with Triazoles Against Multidrug-Resistant Candida auris
por: Badalii, Hamid
Publicado: (2017)

Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel
por: Ben-Ami, Ronen, et al.
Publicado: (2017)

Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris
por: Sherry, Leighann, et al.
Publicado: (2017)

Multi-omics Signature of Candida auris, an Emerging and Multidrug-Resistant Pathogen
por: Zamith-Miranda, Daniel, et al.
Publicado: (2019)

Small molecules for combating multidrug-resistant superbug Candida auris infections
por: Tu, Jie, et al.
Publicado: (2022)

Nanotechnology-Based Strategies to Combat Multidrug-Resistant Candida auris Infections
por: Hetta, Helal F., et al.
Publicado: (2023)

Challenges in the diagnosis and treatment of candidemia due to multidrug-resistant Candida auris
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2023)

1724. Plasmid-free CRISPR-Cas9 System for Genetic Engineering of Rhizopus delemar
por: Gu, Yiyou, et al.
Publicado: (2019)

Candida haemulonii Complex and Candida auris: Biology, Virulence Factors, Immune Response, and Multidrug Resistance
por: Gómez-Gaviria, Manuela, et al.
Publicado: (2023)

1268. Transmissibility of Candida auris by Type of Inpatient Healthcare Facility
por: Paul, Prabasaj, et al.
Publicado: (2018)

The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection
por: Uppuluri, Priya, et al.
Publicado: (2018)

Protective Efficacy of Anti-Hyr1p Monoclonal Antibody against Systemic Candidiasis Due to Multi-Drug-Resistant Candida auris
por: Singh, Shakti, et al.
Publicado: (2023)

Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris
por: Chatterjee, Sharanya, et al.
Publicado: (2015)

The lurking scourge of multidrug resistant Candida auris in times of COVID-19 pandemic
por: Chowdhary, Anuradha, et al.
Publicado: (2020)

Emergence and Genomic Characterization of Multidrug Resistant Candida auris in Nigeria, West Africa
por: Oladele, Rita, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uilaqd5vt54eegd912tm0m3f2j